Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 4
2005 4
2006 1
2007 1
2008 3
2009 6
2010 11
2011 5
2012 2
2013 4
2014 6
2015 4
2016 5
2017 9
2018 6
2019 3
2020 3
2021 4
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Recurrence characteristics after focal salvage HDR brachytherapy in prostate cancer.
Rasing MJA, Peters M, van Son M, Moerland MA, Eppinga W, van de Pol SMG, Noteboom J, Lagendijk J, van der Voort van Zyp JRN. Rasing MJA, et al. Among authors: moerland ma. Radiother Oncol. 2023 Mar;180:109495. doi: 10.1016/j.radonc.2023.109495. Epub 2023 Jan 25. Radiother Oncol. 2023. PMID: 36708924 Free article.
Value of Targeted Biopsies and Combined PSMA PET/CT and mp-MRI Imaging in Locally Recurrent Prostate Cancer after Primary Radiotherapy.
Rasing M, van Son M, Moerland M, de Keizer B, Wessels F, Jonges T, van de Pol S, Eppinga W, Noteboom J, Lagendijk J, van der Voort van Zijp J, Peters M. Rasing M, et al. Among authors: moerland m. Cancers (Basel). 2022 Feb 3;14(3):781. doi: 10.3390/cancers14030781. Cancers (Basel). 2022. PMID: 35159048 Free PMC article.
Development and internal validation of multivariable prediction models for biochemical failure after MRI-guided focal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer.
Willigenburg T, van Son MJ, van de Pol SMG, Eppinga WSC, Lagendijk JJW, de Boer HCJ, Moerland MA, van der Voort van Zyp JRN, Peters M. Willigenburg T, et al. Among authors: moerland ma. Clin Transl Radiat Oncol. 2021 Jun 29;30:7-14. doi: 10.1016/j.ctro.2021.06.005. eCollection 2021 Sep. Clin Transl Radiat Oncol. 2021. PMID: 34278009 Free PMC article.
In Reply to Murgic and Chung.
van Son MJ, Peters M, Moerland MA, van der Voort van Zyp JRN. van Son MJ, et al. Among authors: moerland ma. Int J Radiat Oncol Biol Phys. 2021 Jun 1;110(2):618-619. doi: 10.1016/j.ijrobp.2021.01.021. Int J Radiat Oncol Biol Phys. 2021. PMID: 33989587 No abstract available.
Focal salvage treatment for radiorecurrent prostate cancer: A magnetic resonance-guided stereotactic body radiotherapy versus high-dose-rate brachytherapy planning study.
Willigenburg T, Beld E, Hes J, Lagendijk JJW, de Boer HCJ, Moerland MA, van der Voort van Zyp JRN. Willigenburg T, et al. Among authors: moerland ma. Phys Imaging Radiat Oncol. 2020 Aug 7;15:60-65. doi: 10.1016/j.phro.2020.07.006. eCollection 2020 Jul. Phys Imaging Radiat Oncol. 2020. PMID: 33458327 Free PMC article.
In Reply to David and Kamrava.
Juliet van Son M, Peters M, Moerland MA, van der Voort van Zyp JRN. Juliet van Son M, et al. Among authors: moerland ma. Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1183-1184. doi: 10.1016/j.ijrobp.2019.05.017. Int J Radiat Oncol Biol Phys. 2019. PMID: 31327420 No abstract available.
70 results